The DOI matches its Crossref record; 72 of the 74 references it cites were found in a registry or an index, and 2 are not checked yet.
Macrophage PPARγ is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones
Open accessAbstract
PPAR gamma is required for fat cell development and is the molecular target of antidiabetic thiazolidinediones (TZDs), which exert insulin-sensitizing effects in adipose tissue, skeletal muscle, and liver. Unexpectedly, we found that inactivation of PPAR gamma in macrophages results in the development of significant glucose intolerance plus skeletal muscle and hepatic insulin resistance in lean mice fed a normal diet. This phenotype was associated with increased expression of inflammatory markers and impaired insulin signaling in adipose tissue, muscle, and liver. PPAR gamma-deficient macrophages secreted elevated levels of factors that impair insulin responsiveness in muscle cells in a manner that was enhanced by exposure to FFAs. Consistent with this, the relative degree of insulin resistance became more severe in mice lacking macrophage PPAR gamma following high-fat feeding, and these mice were only partially responsive to TZD treatment. These findings reveal an essential role of PPAR gamma in macrophages for the maintenance of whole-body insulin action and in mediating the antidiabetic actions of TZDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies in PPARγ deficient mice exhibit impaired M2 macrophage function and susceptibility to diet-induced inflammation and insulin resistance [29,65–67].”
From Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine (2012) · cites this paper as [66]
In the citing paper
“thus providing a potential mechanism by which activation of macrophage PPARγ reduces inflammation and enhances insulin sensitivity (106).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [106]
In the citing paper
“Treatment of macrophages with the insulin-sensitizing drugs thiazolidinediones (TZDs), which are PPARγ ligands, polarizes macrophages toward the M2/antiinflammatory state, thus providing a potential mechanism by which activation of macrophage PPARγ reduces inflammation and enhances insulin sensitivity (106).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,720
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,645
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Self-citation
Flagged first, then by citations
Research works printed but not linked: 3
- Ibrahimi, 1994, Mol. Pharmacol., 46, 1070
- 10.1172/JCI200525102 · DOI · Paper page
- 10.1172/JCI200419528 · DOI
Cited by
Sorted by citations
Items 201–300 of 457
Samokhvalov, V., Bilan, P. J., Schertzer, J. D., Antonescu, C. N., & Klip, A. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90667.2008 · Cited by 69
“Western Diet”-Induced Adipose Inflammation Requires a Complex Gut Microbiota
Tran, H. Q., Bretin, A., Adeshirlarijaney, A., Yeoh, B. S., Vijay–Kumar, M., Zou, J., Denning, T. L., Chassaing, B., & Gewirtz, A. T. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.09.009 · Cited by 74
Varga, T., & Nagy, L. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02022.x · Cited by 70
Uribarri, J., Cai, W., Pyzik, R., Goodman, S., Chen, X., Zhu, L., Ramdas, M., Striker, G. E., & Vlassara, H. (2013) · Amino Acids · doi:10.1007/s00726-013-1502-4 · Cited by 67
Autoimmune responses and inflammation in type 2 diabetes
Prasad, M., Chen, E. W., Toh, S.-A. E. S., & Gascoigne, N. R. J. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0220-243r · Cited by 68
The Ability of Exercise-Associated Oxidative Stress to Trigger Redox-Sensitive Signalling Responses
Webb, R., Hughes, M. G., Thomas, A. J., & Morris, K. (2017) · Antioxidants · doi:10.3390/antiox6030063 · Cited by 66
Human adipose dynamics and metabolic health
Feng, B., Zhang, T., & Xu, H. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12009 · Cited by 66
Lee, J.-T., Pamir, N., Liu, N.-C., Kirk, E. A., Averill, M. M., Becker, L., Larson, I. A., Hagman, D. K., Foster‐Schubert, K. E., Yserloo, B. V., et al. (2014) · Endocrinology · doi:10.1210/en.2014-1037 · Cited by 70
Maluf, F. C., Feder, D., & Carvalho, A. A. D. S. (2019) · Parkinson s Disease · doi:10.1155/2019/4951379 · Cited by 65
Inflammatory Bowel Disease: New Insights into the Interplay between Environmental Factors and PPARγ
Caioni, G., Viscido, A., d’Angelo, M., Panella, G., Castelli, V., Merola, C., Frieri, G., Latella, G., Cimini, A., & Benedetti, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22030985 · Cited by 63
Górnicka, A., Fettig, J., Eguchi, A., Berk, M. P., Thapaliya, S., Dixon, L. J., & Feldstein, A. E. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00022.2012 · Cited by 68
Lipid‐sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome
Vacca, M., Degirolamo, C., Mariani‐Costantini, R., Palasciano, G., & Moschetta, A. (2011) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.137 · Cited by 66
Fatty Acid and Glucose Sensors in Hepatic Lipid Metabolism: Implications in NAFLD
Allison, M., Griffin, J. L., Vacca, M., & Vidal‐Puig, A. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1562945 · Cited by 67
Adipose tissue insulin action and IL-6 signaling after exercise in obese mice
MACPHERSON, R. E. K., HUBER, J. S., FRENDO-CUMBO, S., SIMPSON, J. A., & WRIGHT, D. C. (2015) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000660 · Cited by 62
Biology and Therapeutic Applications of Peroxisome Proliferator- Activated Receptors
P. Menendez-Gutierrez, M., Roszer, T., & Ricote, M. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612799436669 · Cited by 62
Self-citationPande, R. L., Brown, J., Buck, S., Redline, W. M., Doyle, J., Plutzky, J., & Creager, M. A. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.06.116 · Cited by 62
C/EBPα regulates macrophage activation and systemic metabolism
Lee, B., Qiao, L., Lu, M. M., Yoo, H. S., Cheung, W., MAK, R. H. K., Schaack, J. B., Feng, G., Chi, N., Olefsky, J. M., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00002.2014 · Cited by 63
Self-citationYin, Y., Hao, H., Cheng, Y., Gao, J., Liu, J., Xie, Z., Zhang, Q., Zang, L., Han, W., & Mu, Y. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.04.051 · Cited by 63
Rosiglitazone-loaded nanospheres for modulating macrophage-specific inflammation in obesity
Mascolo, D. D., Lyon, C. J., Aryal, S., Ramirez, M., Wang, J., Candeloro, P., Guindani, M., Hsueh, W. A., & Decuzzi, P. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.06.012 · Cited by 64
Macrophage PPARγ inhibits Gpr132 to mediate the anti-tumor effects of rosiglitazone
Cheng, W. Y., Huynh, H., Chen, P., Peña‐Llopis, S., & Wan, Y. (2016) · eLife · doi:10.7554/elife.18501 · Cited by 60
Menn, G. L., & Neels, J. G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061575 · Cited by 61
Prediabetes: The Importance of Early Identification and Intervention
Hsueh, W. A., Orloski, L., & Wyne, K. L. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.07.2180 · Cited by 62
Rao, X., Zhong, J., & Sun, Q. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.09.015 · Cited by 58
HDACs class II-selective inhibition alters nuclear receptor-dependent differentiation
Nebbioso, A., Dell’Aversana, C., Bugge, A. K., Sarno, R., Valente, S., Rotili, D., Manzo, F., Teti, D. V., Mandrup, S., Ciana, P., et al. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-10-0043 · Cited by 59
Kewalramani, G., Fink, L. N., Asadi, F., & Klip, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026947 · Cited by 57
Obesity and metabolic inflammation
Xu, H. (2013) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2013.03.006 · Cited by 56
Yang, Z., Wang, X., He, Y., Qi, L., Yu, L., Xue, B., & Shi, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049935 · Cited by 58
Marathe, C., Bradley, M. N., Hong, C., Chao, L. C., Wilpitz, D. C., Salazar, J. V., & Tontonoz, P. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800189-jlr200 · Cited by 56
Wong, J., McLennan, S. V., Molyneaux, L. M., Min, D., Twigg, S. M., & Yue, D. K. (2009) · Diabetologia · doi:10.1007/s00125-009-1424-6 · Cited by 57
Macrophage Heterogeneity: Relevance and Functional Implications in Atherosclerosis
Stöger, J. L., Goossens, P., & de Winther, M. P. J. (2010) · Current Vascular Pharmacology · doi:10.2174/157016110790886983 · Cited by 54
Obesity, adipogenesis and insulin resistance
Pérez, M. R., & Medina‐Gómez, G. (2011) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2011.05.004 · Cited by 58
Hepatocyte toll-like receptor 4 deficiency protects against alcohol-induced fatty liver disease
Jia, L., Chang, X., Qian, S., Liu, C., Lord, C. C., Ahmed, N., Lee, C. E., Lee, S., Gautron, L., Mitchell, M. C., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.05.015 · Cited by 54
Macrophages, PPARs, and Cancer
Ginderachter, J. A. V., Movahedi, K., den Bossche, J. V., & BAETSELIER, P. D. (2008) · PPAR Research · doi:10.1155/2008/169414 · Cited by 54
Wang, Q. A., Zhang, F., Jiang, L., Ye, R., An, Y., Shao, M., Tao, C., Gupta, R. K., & Scherer, P. E. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00677-17 · Cited by 55
A glimpse of the connection between PPARγ and macrophage
Yu, L., Gao, Y., Aaron, N., & Qiang, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1254317 · Cited by 61
Bouhlel, M. A., Brozek, J., Derudas, B., Zawadzki, C., Jude, B., Staels, B., & Chinetti, G. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.047 · Cited by 53
Alnaeeli, M., Raaka, B. M., Gavrilova, O., Teng, R., Chanturiya, T., & Noguchi, C. T. (2014) · Diabetes · doi:10.2337/db13-0883 · Cited by 53
Functional crosstalk of PGC-1 coactivators and inflammation in skeletal muscle pathophysiology
Eisele, P. S., & Handschin, C. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0406-4 · Cited by 54
Ruffino, J. S., Davies, N. A., Morris, K., Ludgate, M., Zhang, L., Webb, R., & Thomas, A. W. (2016) · European Journal of Applied Physiology · doi:10.1007/s00421-016-3414-y · Cited by 56
The Impact of Skeletal Muscle ERα on Mitochondrial Function and Metabolic Health
Hevener, A. L., Ribas, V., Moore, T. M., & Zhou, Z. (2020) · Endocrinology · doi:10.1210/endocr/bqz017 · Cited by 54
Self-citationFat‐resident T regs: an emerging guard protecting from obesity‐associated metabolic disorders
Chen, X., Wu, Y., & Wang, L. (2013) · Obesity Reviews · doi:10.1111/obr.12033 · Cited by 53
Role of nuclear receptor corepressor RIP140 in metabolic syndrome
Rosell, M., Jones, M. C., & Parker, M. G. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.016 · Cited by 53
Sobolev, V. V., Tchepourina, E., Korsunskaya, I. M., Geppe, N. A., Chebysheva, S. N., Soboleva, A. G., & Mezentsev, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179708 · Cited by 56
Commonalities in the Association between PPARG and Vitamin D Related with Obesity and Carcinogenesis
Bandera-Merchán, B., Tinahones, F. J., & Macías‐González, M. (2016) · PPAR Research · doi:10.1155/2016/2308249 · Cited by 50
Shen, J., Yang, T., Xu, Y., Luo, Y., Zhong, X., Shi, L., Hu, T., Guo, T., Nie, Y., Luo, F., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103022 · Cited by 50
Reappraising the stereotypes of diabetes in the modern diabetogenic environment
Wentworth, J. M., Fourlanos, S., & Harrison, L. C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.149 · Cited by 53
Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease
Marchesi, C., Rehman, A., Rautureau, Y., Kasal, D. A. B., Briet, M. B., Leibowitz, A., Simeone, S., Ebrahimian, T., Neves, M. F., Offermanns, S., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs362 · Cited by 49
Self-citationObesidad, adipogénesis y resistencia a la insulina
Pérez, M. R., & Medina‐Gómez, G. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2011.05.008 · Cited by 58
Mulder, P., van den Hoek, A. M., & Kleemann, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169740 · Cited by 52
Chen, Y., Fang, W., Wang, C., Kao, T., Yang, H., Wu, C., Sun, Y., Wang, Y.-C., & Chen, W. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214994 · Cited by 50
Thakur, K., Zhu, Y.-Y., Feng, J., Zhang, J., Hu, F., Prasad, C., & Wei, Z. (2020) · Food & Function · doi:10.1039/d0fo01444c · Cited by 47
Regulation of Chemokine and Chemokine Receptor Expression by PPARγ in Adipocytes and Macrophages
Nguyen, M. T. A., Chen, A., Lu, W. J., Fan, W.-Q., Li, P., Oh, D. Y., & Patsouris, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034976 · Cited by 17
Self-citationWang, G.-X., Cho, K. W., Uhm, M., Hu, C.-R., Li, S., Cozacov, Z., Xu, A. E., Cheng, J., Saltiel, A. R., Lumeng, C. N.-K., et al. (2013) · Diabetes · doi:10.2337/db13-1139 · Cited by 49
Bervejillo, M. L., & Ferreira, A. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-11488-6_3 · Cited by 50
Nucleotides Released From Palmitate-Challenged Muscle Cells Through Pannexin-3 Attract Monocytes
Pillon, N. J., Li, Y. E., Fink, L. N., Brozinick, J. T., Nikolayev, A., Kuo, M., Bilan, P. J., & Klip, A. (2014) · Diabetes · doi:10.2337/db14-0150 · Cited by 46
Eeckhoute, J., Oger, F., Staels, B., & Lefèbvre, P. (2012) · PPAR Research · doi:10.1155/2012/164140 · Cited by 45
Boon, M. R., Bakker, L. E. H., Haks, M. C., Quinten, E., Schaart, G., van Beek, L., Wang, Y., van Schinkel, L. D., van Harmelen, V., Meinders, A. E., et al. (2014) · Clinical Science · doi:10.1042/cs20140179 · Cited by 45
AMPK regulates macrophage polarization in adipose tissue inflammation and NASH
Weng, S., & Schuppan, D. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.09.031 · Cited by 45
Virtue, S., Masoodi, M., de Weijer, B. A., van Eijk, M., Mok, C. Y. L., Eiden, M. J., Dale, M. M., Pirraco, A., Serlie, M. J. M., Griffin, J. L., et al. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.34 · Cited by 44
Adipose tissue signaling by nuclear receptors in metabolic complications of obesity
Jacobi, D., Stanya, K. J., & Lee, C. (2012) · Adipocyte · doi:10.4161/adip.19036 · Cited by 45
Macrophage/foam cell is an attribute of inflammation: Mechanisms of formation and functional role
Dushkin, M. I. (2012) · Biochemistry (Moscow) · doi:10.1134/s0006297912040025 · Cited by 48
PPARγ: A molecular link between systemic metabolic disease and benign prostate hyperplasia
Jiang, M., Strand, D. W., Franco, O. E., Clark, P. E., & Hayward, S. W. (2011) · Differentiation · doi:10.1016/j.diff.2011.05.008 · Cited by 44
Sima, C., Montero, E., Nguyen, D., Freire, M., Norris, P. C., Serhan, C. N., & Dyke, T. E. V. (2017) · Scientific Reports · doi:10.1038/s41598-017-13185-7 · Cited by 44
PPARγ2Pro12Ala Polymorphism and Human Health
He, W. (2009) · PPAR Research · doi:10.1155/2009/849538 · Cited by 46
Rohm, T. V., Reis, F. C. G., Isaac, R., Murphy, C., Rocha, K. C. E., Bandyopadhyay, G. K., Gao, H., Libster, A. M., Zapata, R. C., Lee, Y. S., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01023-w · Cited by 44
Self-citationSamaan, M. C., Marcinko, K., Sikkema, S. R., Fullerton, M. D., Ziafazeli, T., Khan, M. I., & Steinberg, G. R. (2014) · Physiological Reports · doi:10.14814/phy2.12012 · Cited by 44
Miyatake, S., Bilan, P. J., Pillon, N. J., & Klip, A. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00325.2015 · Cited by 43
Epigenomic and transcriptional control of insulin resistance
Rosen, E. D. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12547 · Cited by 43
PPAR-γ in innate and adaptive lung immunity
Nobs, S. P., & Köpf, M. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0118-034r · Cited by 40
Nuclear Receptors, Inflammation, and Neurodegenerative Diseases
Saijo, K., Crotti, A., & Glass, C. K. (2010) · Advances in immunology · doi:10.1016/s0065-2776(10)06002-5 · Cited by 42
Self-citationPPARγ in Kidney Physiology and Pathophysiology
Kiss-Tóth, É. D., & Rőszer, T. (2008) · PPAR Research · doi:10.1155/2008/183108 · Cited by 40
Dynamic Interplay Between Metabolic Syndrome and Immunity
Paragh, G., Seres, I., Harangi, M., & Fülöp, P. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-07320-0_13 · Cited by 40
Loss of macrophage fatty acid oxidation does not potentiate systemic metabolic dysfunction
Gonzalez-Hurtado, E., Lee, J.-E., Choi, J., Alpergin, E. S. S., Collins, S. L., Horton, M. R., & Wolfgang, M. J. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00408.2016 · Cited by 39
Ah, B., Kosiakova, H. V., Onopchenko, O. V., Panchuk, R. R., Stoika, R. S., & Hula, N. M. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.05.001 · Cited by 39
Orchestration of the Adipose Tissue Immune Landscape by Adipocytes
Bradley, D. P., Deng, T., Shantaram, D., & Hsueh, W. A. (2024) · Annual Review of Physiology · doi:10.1146/annurev-physiol-042222-024353 · Cited by 44
Fujisaka, S., Usui, I., Nawaz, A., Takikawa, A., Kado, T., Igarashi, Y., & Tobe, K. (2016) · Diabetology International · doi:10.1007/s13340-016-0290-y · Cited by 39
ERα in the Control of Mitochondrial Function and Metabolic Health
Hevener, A. L., Ribas, V., Moore, T. M., & Zhou, Z. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.09.006 · Cited by 37
Self-citationEffects of des-acyl ghrelin on insulin sensitivity and macrophage polarization in adipose tissue
Yuan, F., Zhang, Q., Dong, H., Xiang, X., Zhang, W., Zhang, Y., & Li, Y. (2021) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2021-0025 · Cited by 36
Harnessing metabolism of hepatic macrophages to aid liver regeneration
Liu, R., Scimeca, M., Sun, Q., Melino, G., Mauriello, A., Shao, C., Bernassola, F., Bove, P., Candi, E., Valentina, R., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06066-7 · Cited by 38
The Regulatory Network of Transcription Factors in Macrophage Polarization
Liu, J., Wang, M., & Zhao, Y. X. (2025) · ImmunoTargets and Therapy · doi:10.2147/itt.s494550 · Cited by 38
Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes
Han, E., Jang, S., Kim, G., Lee, Y., Choe, E. Y., Nam, C. M., & Kang, E. S. (2016) · Medicine · doi:10.1097/md.0000000000002786 · Cited by 35
Transcriptional control of macrophage polarisation in type 2 diabetes
Drareni, K., Gautier, J., Venteclef, N., & Alzaïd, F. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00748-1 · Cited by 38
Visfatin is induced by peroxisome proliferator‐activated receptor gamma in human macrophages
Mayi, T. H., Duhem, C., Copin, C., Bouhlel, M. A., Rigamonti, E., Pattou, F. N., Staels, B., & Chinetti, G. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07729.x · Cited by 35
PPARδ/β: The Lobbyist Switching Macrophage Allegiance in Favor of Metabolism
Desvergne, B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.05.002 · Cited by 35
Reyna, S. M., Tantiwong, P., Cersósimo, E., DeFronzo, R. A., Sriwijitkamol, A., & Musi, N. (2013) · Journal of Diabetes Research · doi:10.1155/2013/107805 · Cited by 34
The macrophage at the intersection of immunity and metabolism in obesity
Samaan, M. C. (2011) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-3-29 · Cited by 34
Uddin, M. S., Kabir, M. T., Jakaria, M., Mamun, A. A., Niaz, K., Amran, M. S., Barreto, G. E., & Ashraf, G. M. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00047-5 · Cited by 34
Takanabe‐Mori, R., Ono, K., Sowa, N., Wada, H., Takaya, T., Horie, T., Satoh‐Asahara, N., Shimatsu, A., Fujita, M., Sawamura, T., et al. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.06.123 · Cited by 34
Opposite Action of Peroxisome Proliferator-activated Receptor-γ in Regulating Renal Inflammation
Wen, X., Li, Y., & Liu, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.110908 · Cited by 34
Ikeda, S.-I., Tamura, Y., Kakehi, S., Takeno, K., Kawaguchi, M., Watanabe, T., Sato, F., Ogihara, T., Kanazawa, A., Fujitani, Y., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.005 · Cited by 33
Huang, J., Chiang, M., Yet, S., & Chau, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038626 · Cited by 33
Targeting gp130 to prevent inflammation and promote insulin action
Kraakman, M. J., Allen, T. L., Whitham, M., Iliades, P., Kammoun, H. L., Estévez, E., Lancaster, G. I., & Febbraio, M. A. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12170 · Cited by 35
Self-citationChinetti, G., & Staels, B. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.01.009 · Cited by 32
Molecular mechanisms underlying methotrexate-induced intestinal injury and protective strategies
Ali, G. F., Hassanein, E. H. M., & Mohamed, W. R. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03164-x · Cited by 31
Ohashi, W., Hattori, K., & Hattori, Y. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.225540 · Cited by 31
Norheim, F., Bjellaas, T., Hui, S. T. Y., Krishnan, K. C., Lee, J. J., Gupta, S., Pan, C., Hasin-Brumshtein, Y., Parks, B. W., Li, D., et al. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m081398 · Cited by 32
Self-citationPON2 Deficiency Leads to Increased Susceptibility to Diet-Induced Obesity
Shih, D. M., Meng, Y., Sallam, T., Vergnes, L., Shu, M. L., Reue, K., Tontonoz, P., Fogelman, A. M., Lusis, A. J., & Reddy, S. T. (2019) · Antioxidants · doi:10.3390/antiox8010019 · Cited by 32
Lee, J., Woo, Y., Hwang, I., Kim, C.-Y., Kim, D., Shim, C., & Chung, S. (2009) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2009.06.003 · Cited by 31
Alveolar macrophage activation in obese patients with obstructive sleep apnea
Sharma, S., Malur, A., Marshall, I., Huizar, I., Barna, B. P., Pories, W. J., Dohm, L. G., Kavuru, M. S., & Thomassen, M. J. (2011) · Surgery · doi:10.1016/j.surg.2011.06.035 · Cited by 31
The flux of energy in critical illness and the obesity paradox
Jaitovich, A., & Hall, J. B. (2025) · Physiological Reviews · doi:10.1152/physrev.00029.2024 · Cited by 34
Metadata
- Authors
- Hevener, A. L., Olefsky, J. M., Reichart, D., Nguyen, M. T. A., Bandyopadyhay, G., Leung, H.-Y., Watt, M. J., Benner, C., Febbraio, M. A., Nguyen, A.-K., Folian, B., Subramaniam, S., Gonzalez, F. J., Glass, C. K., & Ricote, M.
- Affiliations
- University of California San Diego (US)
- University of California System (US)
- The University of Melbourne (AU)
- Baker Heart and Diabetes Institute (AU)
- National Institutes of Health (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-06-01
- Volume
- 117
- Issue
- 6
- Pages
- 1658-1669
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1868788
- OpenAlex
- W2131598118
- Cited by
- 459
- References
- 71
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 9 · 2023: 9 · 2022: 10 · 2021: 10 · 2020: 13 · 2019: 17 · 2018: 23 · 2017: 22 · 2016: 18 · 2015: 28 · 2014: 32 · 2013: 49 · 2012: 41
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- Pfizer
- Takeda Pharmaceutical Company
- Ministerio de Economía y Competitividad
- National Institutes of Health (DK 074868, DK-063491, GM-069338)
- University of California, San Diego (DK063491)
- National Heart, Lung, and Blood Institute (P50HL056989, HL-56989)
- National Institute of General Medical Sciences (U54GM069338, GM 069338)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK063491, DK 074868, DK 60484, DK-33651, K01DK060484, R37DK033651, R21DK073227, P01DK074868, DK73227, R01DK033651, P30DK063491)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- PPARγ, macrophages, thiazolidinediones, insulin resistance, insulin sensitivity, skeletal muscle, liver, adipose tissue, impaired glucose tolerance, inflammation, insulin signaling, fatty acids, high-fat diet, antidiabetic drugs
- MeSH terms
- Animals, Base Sequence, Hypoglycemic Agents, Insulin Resistance, Liver, Macrophages, Mice, Transgenic, Promoter Regions, Genetic, Adipocytes, DNA Primers, Mice, Knockout, Muscle, Skeletal, Gene Expression Profiling, Thiazolidinediones, PPAR gamma, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review